TTRX
HealthcareTurn Therapeutics Inc.
$4.73
+$0.04 (+0.85%)
Jan 5, 2026
Price History (1Y)
Analysis
Turn Therapeutics Inc. is a biotechnology company listed in the healthcare sector with a market capitalization of $139.28M. The company operates in the industry of biotechnology but does not disclose its employee count. The financial health of Turn Therapeutics Inc. indicates significant losses, with net income (TTM) at -$3,796,280 and EBITDA at -$3,943,078. Additionally, free cash flow is -$587,974, while cash on hand is $3.11M, supported by debt of $91,173. Margins are zero across all categories, and returns on equity and assets are negative at -2324.8% and -78.7%, respectively. The company's balance sheet reflects a current ratio of 1.43. Turn Therapeutics Inc.'s valuation is characterized by a forward P/E ratio of -47.30, a price-to-book ratio of 262.78, and an EV/EBITDA of -34.26. The 52-week high and low are $26.50 and $2.57, respectively, while the beta value is not available.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Turn Therapeutics Inc.
Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic resistance through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.
Visit website →Key Statistics
- Market Cap
- $139.28M
- P/E Ratio
- N/A
- 52-Week High
- $26.50
- 52-Week Low
- $2.57
- Avg Volume
- 466.38K
Company Info
- Industry
- Biotechnology
- Exchange
- NGM
- Country
- United States